Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Stomach Cancer Clinical Trials
Stomach Cancer clinical trials are recruiting across 117 cities. Here are the cities with the most active studies:
Stomach Cancer Trial Phases
30 research organizations are sponsoring stomach cancer trials.
About Stomach Cancer
Stomach (gastric) cancer develops in the lining of the stomach and is more common in certain regions of the world. Risk factors include H. pylori infection, smoking, and diet. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.
Clinical trials are advancing new treatments for stomach cancer. Currently, 47 studies are recruiting a combined 12,908 participants across the United States. Research is being conducted by 30 organizations including AstraZeneca, University of Chicago, Daiichi Sankyo and 27 others.
2026 Stomach Cancer Research Landscape
As of July 2026, the stomach cancer clinical trial landscape includes 47 actively recruiting studies across 117 cities in the United States. These studies are collectively seeking 12,908 participants, with an average enrollment target of 275 per study.
The research spans multiple phases of development: 21 studies are in PHASE2, 12 studies are in PHASE1, 9 studies are in PHASE3, 3 studies are in NA, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some stomach cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 30 different organizations, including AstraZeneca, University of Chicago, Daiichi Sankyo, Stanford University, Shanghai Henlius Biotech, and 25 others. The large number of sponsors reflects significant research interest and investment in stomach cancer treatment advancement.
Geographically, stomach cancer trials are most concentrated in Duarte, California (10 trials); New York, New York (9 trials); Chicago, Illinois (7 trials); Houston, Texas (7 trials); Santa Monica, California (6 trials) and 7 other cities.
Featured Stomach Cancer Studies
Highlighted recruiting studies for stomach cancer, selected by enrollment size and research scope.
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
The purpose of this study is to evaluate the efficacy and safety of sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in first-line (1L) Claudin18.2 (CLDN18.2)-positive, human epidermal growth factor receptor 2 (HER2)-negative, gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma.
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
The purpose of this study is to collect and store normal and malignant tissue from patients with gastric cancer, GIST, esophageal cancer, pancreas cancer, hepatocellular cancer, biliary cancer, neuroendocrine, peritoneal mesothelioma, anal cancer and colorectal cancer, an estimated 50 to 100 of each tumor type. To collect and store blood samples from patients with gastric cancer, GIST, esophageal ...
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and safety of rilvegostomig in combination with fluoropyrimidine and T-DXd (Arm A) compared to trastuzumab, chemotherapy, and pembrolizumab (Arm B) in HER2-positive locally advanced or metastatic gastric or GEJ adenocarcinoma participants whose tumors express PD L1 CPS ≥ 1. Rilvegost...
Frequently Asked Questions About Stomach Cancer Clinical Trials
Are there stomach cancer clinical trials near me?
Yes, there are 47 stomach cancer clinical trials currently recruiting across 117+ cities in the United States, including Duarte, California; New York, New York; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a stomach cancer clinical trial?
To join a stomach cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are stomach cancer clinical trials free?
Yes, participation in stomach cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of stomach cancer treatments are being studied?
Current stomach cancer clinical trials are testing a range of approaches across PHASE2 (21 studies), PHASE1 (12 studies), PHASE3 (9 studies), NA (3 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 30 research organizations.
Is it safe to participate in stomach cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov